How to Read: Global cancer statistics [Reading Guide]

This guide will help you efficiently read "Global cancer statistics, 2011" by Siegel et al., published in CA: A Cancer Journal for Clinicians. This paper provides a comprehensive overview of global cancer incidence and mortality based on 2008 GLOBOCAN estimates, highlighting disparities and prevention opportunities.

First pass (5–10 min)

The goal of the first pass is to get a high-level understanding of the paper's scope, main findings, and relevance.

• What to skim:

  • Title: "Global cancer statistics" immediately tells you the paper's subject matter.
  • Abstract: Read this carefully. It summarizes the global burden, key cancer types (breast, lung), sex differences, disparities between developed and developing countries, and the potential for prevention. Note the core statistics: 12.7 million cases, 7.6 million deaths in 2008.
  • Introduction (pages 209-210): Focus on the first and last paragraphs. The introduction sets the context for the increasing global cancer burden and the purpose of the paper: to provide updated statistics and discuss implications for cancer control.
  • Conclusion (page 230): Read the final paragraphs to grasp the main takeaways and calls to action, particularly regarding prevention and early detection.
  • Headings and Subheadings: Quickly scan through the main sections like "Methods," "Results," "Discussion," and their subheadings to understand the paper's structure and the topics covered.

• What to notice:

  • Contributions: The paper provides the most up-to-date global cancer statistics (as of 2011, using 2008 data), broken down by sex, region, and economic development status. It identifies leading cancer types and highlights disparities.
  • Problem: The increasing global burden of cancer, particularly in developing countries, and the need for effective control strategies.
  • Setting: Global, with specific comparisons between economically developed and developing countries, and breakdowns by world region.
  • Key numbers: Note the overall incidence and mortality figures from the abstract (12.7 million cases, 7.6 million deaths).

Second pass (up to 1 hour)

Using SpatialRead in the Second Pass

• Use the Screenshot tool to capture figures, tables, diagrams, and formulae from the PDF and use AI for simple explanations.
• Ask: "Explain Figure X at a high level", "Compare Table 2 vs 3", or "What does the y-axis represent here?"
• Download SpatialRead →

In the second pass, you'll dive deeper into the core findings, focusing on the data and key interpretations.

• What sections/figures to focus on:

  • Methods (page 210): Briefly review the "Data Sources" and "Statistical Analysis" sections to understand how the GLOBOCAN 2008 estimates were derived. This helps contextualize the data's reliability.
  • Results (pages 210-229): This is the most data-rich section. Focus on the figures and tables that present the main findings:
    • Figure 1: Provides a quick visual summary of estimated new cancer cases and deaths worldwide.
    • Figure 2: Illustrates age-standardized incidence and mortality rates, clearly showing the disparity between developed and developing regions.
    • Figure 5: "Estimated number of new cancer cases and deaths for the 10 most common cancers by sex, 2008" is crucial for understanding the global burden of specific cancers.
    • Figure 7 and Figure 8: Compare the top 10 cancers in economically developed versus developing countries, highlighting significant differences (e.g., breast cancer's prominence in both, but different profiles for other cancers).
    • Table 1: "Estimated number of new cancer cases, deaths, and age-standardized rates by world region and income level, 2008" offers a detailed breakdown of the global burden.
    • Table 2: "Estimated number of new cancer cases, deaths, and age-standardized rates for the 10 most common cancers by sex and world region, 2008" is highly detailed and allows for specific regional comparisons of cancer types.
    • Discussion (pages 229-230): Read this section to understand the authors' interpretation of the results, the reasons behind observed trends (e.g., aging populations, lifestyle changes), and the implications for public health. Pay attention to the discussion of prevention strategies.

• Key terms/questions to note:

  • Age-standardized rates: Why are these used? (To allow for comparisons between populations with different age structures).
  • Developed vs. Developing countries: What are the key differences in cancer profiles and mortality rates?
  • Leading cancers: Which cancers are most prevalent and deadly globally, and how do these differ by sex and region? (e.g., breast, lung, colorectal, prostate, stomach, liver, cervical).
  • Risk factors: What factors are identified as driving the increase in cancer burden (e.g., smoking, diet, infections)?
  • Prevention opportunities: What interventions are highlighted (e.g., tobacco control, vaccination, early detection)?

Third pass (1–5 hours)

Using SpatialRead in the Third Pass

• Highlight complex keywords, dense paragraphs, equations, or proofs and ask for a plain-English explanation that preserves notation.
• Use AI to explain the concepts in a way that is easy to understand.
• Ask for alternative phrasings or analogies to confirm understanding without changing technical meaning.
• Connect concepts with each other using AI to build a comprehensive understanding of the paper.
• Download SpatialRead →

The third pass involves a deep, critical reading of the entire paper, scrutinizing the details, methods, and implications.

• Deep reading guidance:

  • Methods (pages 210): Read the "Data Sources" and "Statistical Analysis" sections thoroughly. Understand the limitations of using GLOBOCAN estimates, particularly regarding data quality and completeness in certain regions.
  • Results (pages 210-229): Go through the narrative text of the results section in conjunction with the figures and tables. Pay close attention to the specific numbers and trends discussed. For example, when reading about breast cancer, refer to Figure 5, Figure 7, Figure 8, and Tables 2, 3, and 4 to see the specific data points.
  • Discussion (pages 229-230): Critically evaluate the authors' interpretations. Do their conclusions logically follow from the data presented? Consider the broader implications of the findings for policy and clinical practice.
  • Limitations: While not a dedicated section, the discussion often touches upon limitations of the data or methodology. For example, the authors mention that "the quality of the underlying cancer incidence and mortality data varies widely across countries" (page 210). Identify these to understand the scope and generalizability of the findings.
  • References: Skim the reference list to identify key foundational papers or related research that might be useful for further reading.

• Replication pointers (if applicable):

  • This paper primarily presents statistical estimates rather than experimental results, so direct "replication" in the traditional sense isn't applicable.
  • However, you can assess the transparency of their methods. The paper clearly states its reliance on GLOBOCAN 2008 data and the methods used for estimation. If you wanted to update these statistics, you would need access to similar national cancer registry data and apply comparable statistical methods, as outlined in the "Methods" section. The authors provide sufficient detail for someone with expertise in epidemiology and biostatistics to understand their approach.